Poster at PVRI Congress 2022: Comparison between PAH risk assessment methods including PHORA

Fauvel, C., Liu, Z., Lin, S., Correa-Jaque, P., Webb, A., Vanderpool, R., Kanwar, M., Kraisangka, J., Mathur, P., Perer, A., Everett, A., & Benza, R. L. “Comparison between PAH risk assessment methods including PHORA”. BACKGROUND. Risk assessment is critical to predict survival and then guide therapeutic management for pulmonary arterial hypertension (PAH) patients. Several risk […]

Poster at PHA 2022 Conference: Pulmonary Arterial Hypertension Risk Assessment model using Random Forrest and Bayesian Network

Liu, Z., Fauvel, C., Lin, S., Correa-Jaque, P., Webb, A., Vanderpool, R., Kanwar, M., Kraisangka, J., Mathur, P., Perer, A., Everett, A., & Benza, R. L. “Pulmonary Arterial Hypertension Risk Assessment model using Random Forrest and Bayesian Network”. Background and rationale: Existing risk assessment models in pulmonary arterial hypertension (PAH) are powerful in predicating survival. […]

Poster at PHA 2022 Conference: Pulmonary Arterial Hypertension risk assessment genomic model using Bayesian Network

Fauvel, C., Webb, A., Liu, Z., Lin, S., Correa-Jaque, P., & Benza, R. L. “Pulmonary Arterial Hypertension risk assessment genomic model using Bayesian Network”. BACKGROUND AND RATIONALE. Accurate risk assessment is essential to making individualized treatment decision in pulmonary arterial hypertension (PAH) patients. Yet, existing probabilistic risk assessment models are insufficient since they did not […]